Related Experiment Video
Updated: Jul 19, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study
Elena Olmastroni1, Julius L Katzmann2, Federica Galimberti3
1Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; IRCCS MultiMedica, Sesto San Giovanni (MI), Italy.
Elevated lipoprotein(a) [Lp(a)] is linked to myocardial infarction (MI) risk, but not venous thromboembolism (VTE). This study found no evidence that Lp(a) increases MI risk through prothrombotic effects.
Area of Science:
- Cardiovascular Genetics
- Thrombosis Research
- Lipid Metabolism
Background:
- The role of lipoprotein(a) [Lp(a)] in myocardial infarction (MI) risk is established, yet its prothrombotic contribution remains unclear.
- Investigating the prothrombotic effects of Lp(a) is crucial for understanding its association with cardiovascular disease.
- Lipoprotein(a) is an independent risk factor for atherosclerotic cardiovascular disease.
Purpose of the Study:
- To determine if lipoprotein(a) [Lp(a)] has prothrombotic effects contributing to its association with myocardial infarction (MI) risk.
- To investigate the association of LPA genetic variants and Lp(a) concentrations with venous thromboembolism (VTE) and MI risk.
- To assess whether coagulation pathways modify the relationship between Lp(a) and MI risk.
Main Methods:
- Utilized UK Biobank data from 410,177 participants.
- Examined associations of LPA genetic variants and Lp(a) concentrations with VTE and MI risk.
- Stratified analyses by genetic scores for thrombin (F2/F5) and platelet (GUCY1A3) pathways.
Main Results:
- Neither LPA genetic variants nor Lp(a) concentrations were associated with VTE risk.
- A strong association was observed between higher Lp(a) concentrations and increased MI risk (HR 1.31 per 100 nmol/L).
- The association between Lp(a) and MI risk was not modified by genetic scores influencing coagulation.
Conclusions:
- The link between lipoprotein(a) [Lp(a)] and myocardial infarction (MI) is not mediated by genetically determined coagulation activity.
- Findings do not support a prothrombotic mechanism for Lp(a)-associated MI risk.
- Lp(a) may increase MI risk through non-thrombotic pathways.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

